Clinical trial
Voice as a Digital Biomarker of Neurotoxicity in CAR T-Cell Therapy
NCT07249528 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Voice as a Digital Biomarker of Neurotoxicity in CAR T-Cell Therapy
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- April 17, 2026
- Completion date
- December 31, 2027
- Enrollment
- 20 (estimated)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
multiple myeloma, non-hodgkin lymphoma